Debridement agents: Nursing pharmacology

Debridement agents: Nursing pharmacology

gap test med surg

gap test med surg

Aortic aneurysm: Nursing process (ADPIE)
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Hypertension: Nursing process (ADPIE)
Left-sided heart failure: Nursing process (ADPIE)
Myocardial infarction (MI): Nursing process (ADPIE)
Pericardial effusion and cardiac tamponade: Nursing process (ADPIE)
Rheumatic heart disease: Nursing process (ADPIE)
Antihyperlipidemics - Statins: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Diabetes insipidus: Nursing process (ADPIE)
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Hyperosmolar hyperglycemic state (HHS): Nursing process (ADPIE)
Hyperthyroidism: Nursing process (ADPIE)
Hypothyroidism: Nursing process (ADPIE)
Syndrome of inappropriate antidiuretic hormone (SIADH): Nursing process (ADPIE)
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Insulin: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Epistaxis: Nursing process (ADPIE)
Eye injury: Nursing process (ADPIE)
Glaucoma: Nursing process (ADPIE)
Tonsillitis: Nursing process (ADPIE)
Antiglaucoma medications: Nursing pharmacology
Eye anesthetics: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Laxatives: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Antiemetics: Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Acute kidney injury (AKI): Nursing process (ADPIE)
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Urinary incontinence - Stress: Nursing process (ADPIE)
Urinary tract infections (UTIs): Nursing process (ADPIE)
Hemophilia: Nursing process (ADPIE)
Leukemia: Nursing process (ADPIE)
Sickle cell disease: Nursing process (ADPIE)
Anticoagulants - Heparin: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Hemostatics: Nursing pharmacology
Iron preparations: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Blood products: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Vaccines: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Atopic dermatitis: Nursing process (ADPIE)
Frostbite: Nursing process (ADPIE)
Methicillin-resistant Staphylococcus aureus (MRSA): Nursing process (ADPIE)
Pressure injury: Nursing process (ADPIE)
Debridement agents: Nursing pharmacology
Keratolytics: Nursing pharmacology
Antibiotics - Topical: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Acute compartment syndrome: Nursing process (ADPIE)
Fractures: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Analgesics: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Skeletal muscle relaxants: Nursing pharmacology
Medications for migraines: Nursing pharmacology
Meningitis: Nursing process (ADPIE)
Parkinson disease: Nursing process (ADPIE)
Seizure disorder: Nursing process (ADPIE)
Stroke: Nursing process (ADPIE)
Trigeminal neuralgia: Nursing process (ADPIE)
Breast cancer: Nursing process (ADPIE)
Tumor lysis syndrome (TLS): Nursing Process (ADPIE)
Plant extracts for chemotherapy: Nursing pharmacology
Antitumor antibiotics: Nursing pharmacology
Alkylating agents: Nursing pharmacology
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Candidiasis: Nursing process (ADPIE)
Gonorrhea and chlamydia: Nursing process (ADPIE)
Pelvic inflammatory disease (PID): Nursing process (ADPIE)
Asthma: Nursing process (ADPIE)
Bacterial pneumonia: Nursing process (ADPIE)
Carbon monoxide poisoning: Nursing process (ADPIE)
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Epiglottitis: Nursing process (ADPIE)
Foreign body aspiration and upper airway obstruction: Nursing process (ADPIE)
Laryngotracheobronchitis (LTB) and croup: Nursing process (ADPIE)
Smoke inhalation injury: Nursing process (ADPIE)
Venous thromboembolism (VTE): Nursing process (ADPIE)
Antihistamines: Nursing pharmacology
Bronchodilators: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Mast cell stabilizers - Inhaled: Nursing pharmacology
Leukotriene modifiers: Nursing pharmacology
Medications to control airway secretions: Nursing pharmacology
Oxygen therapy: Nursing pharmacology

Notes

DEBRIDEMENT AGENTS
DRUG NAME
collagenase (Santyl)
trypsin, balsam peru, 
castor oil (Granulex)
CLASS
Debridement agents
MECHANISM OF ACTION
  • Breaks down collagen in dead tissue and helps with the formation of granulation tissue
  • Trypsin: activates metalloproteinases that break down the intercellular matrix, helping with desquamation
  • Balsam peru: stimulates blood flow to the wound  and inhibits bacterial and fungal growth
  • Castor oil: prevents breakdown of healthy skin cells and inhibits bacterial and fungal growth
INDICATIONS
  • Burns
  • Ulcers
  • Wounds
ROUTE(S) OF ADMINISTRATION
  • TOP
SIDE EFFECTS
  • Erythema
  • Burning
  • Itching
  • Tingling
  • Increased risk of local infection
CONTRAINDICATIONS AND CAUTIONS
  • None
NURSING CONSIDERATIONS: DEBRIDEMENT AGENTS
ASSESSMENT AND MONITORING
Assess
  • Health conditions affecting healing; e.g., impaired mobility, impaired circulation, diabetes, deficient nutrition
  • Wound
    • Location, size, measuring length, width, and depth
    • Necrotic tissue
    • Signs of local infection, including redness, swelling, drainage, warmth, pain, foul odor
    • Demarcation between the necrotic tissue and healthy tissue
  • Laboratory test results, CBC, albumin, hemoglobin, hematocrit; blood glucose, HbA1C
Intervention
  • Clean wound bed with normal saline
  • Apply debridement agent
  • Dress the wound
  • Promote healing
    • Nutrition, glucose control
Evaluate
  • Signs of healing, wound bed clear of necrotic tissue and debris, free of infection
CLIENT EDUCATION
  • Purpose of medication: remove dead tissue, promote healing, prevent infection
  • Tingling or burning sensation with application
Author: Antonia Syrnioti, MD
Illustrator: Robyn Hughes, MScBMC

Transcript

Watch video only

Debridement agents are a group of medications that are used to remove debris or dead tissue from a burn, ulcer, or wound, which helps promote healing and decrease the risk of infection.

Some commonly used debridement agents include collagenase, and a combination medication containing trypsin, balsam peru, and castor oil. These medications come in the form of ointments that are applied topically on the skin.

Once applied, collagenase is an enzyme that acts by breaking down collagen in non-viable tissue, and helps in forming granulation tissue, which contains healthy cells that fill up the dead tissue from the wound and fight off infections.

Similarly, sutilain breaks down proteins of the intercellular matrix, which fills the spaces between neighboring skin cells. This allows the cells of the outer skin layers to shed, which is known as desquamation.

Finally, trypsin activates an enzyme called metalloproteinase, which breaks down the intercellular matrix, making it easier for skin cells to slough off; while balsam peru stimulates blood flow to the wound area, as well as castor oil, which prevents the breakdown of healthy skin cells.

Additionally, both balsam peru and castor oil help prevent wound infection by inhibiting bacterial and fungal growth in the skin.

Unfortunately, debridement agents may cause side effects, such as skin irritation, which can manifest as pain, erythema, as well as a burning, itching, or a tingling sensation.

Luckily, there are no contraindications for the use of debridement agents.

If a client with a necrotic wound is prescribed a debridement agent, first review their medical record for any health conditions that could affect healing, such as impaired mobility, impaired circulation to the wound site, deficient nutrition, or conditions like diabetes mellitus.

Then, perform a baseline assessment of the affected area, noting the location, and size, measuring length, width, and depth of the wound, and the amount of necrotic tissue.

Next, assess for signs of local infection, including redness, swelling, warmth, pain, drainage, or foul odor, and be sure there is a clear line of demarcation between the necrotic tissue and healthy tissue.

Sources

  1. "Focus on Nursing Pharmacology" LWW (2019)
  2. "Pharmacology" Elsevier Health Sciences (2014)
  3. "Mosby's 2021 Nursing Drug Reference" Mosby (2020)
  4. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  5. "Mast cell tryptase and photoaging: possible involvement in the degradation of extra cellular matrix and basement membrane proteins" Archives of Dermatological Research (2007)
  6. "Sleep Hygiene and Melatonin Treatment for Children and Adolescents With ADHD and Initial Insomnia" Journal of the American Academy of Child & Adolescent Psychiatry (2006)